- New U.S. Business Headquarters will Help Drive Product and Geographic
Expansion of ZyGEM's Novel Enzymatic Life Sciences Solutions -
- Company Also Announces Interim Close of Financing Round -
SOLANA BEACH, Calif. and HAMILTON, New Zealand, Jan. 7 /PRNewswire/ --
ZyGEM Corp. Ltd., a leading developer and manufacturer of unique enzymatic
solutions for DNA extraction and detection and other life sciences
applications, today announced the opening of its U.S. headquarters in
Solana Beach, California. Under the direction of recently appointed ZyGEM
president and CEO Paul Kinnon, the U.S. organization will focus on
expanding the company's life sciences product portfolio and geographic
reach, leveraging ZyGEM's proprietary culture collection and expertise in
enzymes isolated from extreme environments. Separately, the company also
announced that it has closed the first round of a financing from existing
private venture investors.
"Establishing our new U.S. business headquarters is a major step in
ZyGEM's global expansion, building on the strong foundation provided by our
New Zealand R&D and headquarters facility," said Mr. Kinnon. "We also are
moving rapidly to broaden the life sciences applications of our innovative
enzyme technology, as well as expanding geographically in North America,
Europe and Asia. The infusion of funds from existing investors in this
first closing of our ongoing financing is helping to fuel these ambitious
efforts, as well as the expansion of our R&D efforts into the clinical
sector."
ZyGEM develops and markets innovative enzyme-based products for life
sciences research and related applications. ZyGEM's current products use
unique enzymes that have been isolated from the company's proprietary
culture collection to provide creative DNA extraction and detection
solutions for a variety of markets, including forensics, livestock and
agriculture, basic research and clinical applications. ZyGEM's technology
and product portfolio are based on more than two decades of research and
development on the company's exclusive collection of microorganisms and
fungi isolated from extreme environments.
Current ZyGEM products encompass a variety of enzyme-based reagents,
including DNA extraction and detection formulations specifically tailored
to the needs of specialty markets such as forensics and high throughput
livestock genetics analysis. Using a unique single closed tube system that
is easily automated with standard robotics, these products provide
significant benefits over existing approaches, including reduced risk of
sample contamination or staff infection, substantial cost savings, much
faster process times, increased accuracy and greater yields from small
samples.
ZyGEM's new U.S. headquarters is located in at 462 Stevens Avenue,
Suite 304, Solana Beach, CA 92075, telephone: (858) 720-8333. Solana Beach
is located in San Diego County, about 30 minutes north of the City of San
Diego.
About ZyGEM
ZyGEM Corporation Limited is a rapidly growing biotechnology company
with a range of innovative enzyme-based products and technologies based on
the company's exclusive collection of microorganisms from extreme
environments. ZyGEM's technology has significant competitive advantages
over existing methods and has potential applications in multiple market
sectors. ZyGEM currently produces DNA extraction and detection products,
molecular biology enzymes and individual enzymes and diagnostics, serving
life sciences customers in basic research, forensics, clinical diagnostics
and agriculture. ZyGEM has facilities in New Zealand and the U.S. For more
information, visit http://www.ZyGEM.com
ZyGEM Corp.: Media:
Paul Kinnon GendeLLindheim BioCom Partners
President and CEO Barbara Lindheim
858 720-8333 212 918-4650
SOURCE ZyGEM Corp. Ltd.
 back to top
Related links:
http://www.ZyGEM.com
CONTACT:
ZyGEM Corp., Paul Kinnon, President and CEO,
+1-858-720-8333; or Media, Barbara Lindheim of GendeLLindheim
BioCom Partners, +1-212 918-4650, for ZyGEM Corp. Ltd.
|
